Cargando…

Clinical significance of the LacdiNAc‐glycosylated prostate‐specific antigen assay for prostate cancer detection

To reduce unnecessary prostate biopsies (Pbx), better discrimination is needed. To identify clinically significant prostate cancer (CSPC) we determined the performance of LacdiNAc‐glycosylated prostate‐specific antigen (LDN‐PSA) and LDN‐PSA normalized by prostate volume (LDN‐PSAD). We retrospectivel...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yoneyama, Tohru, Tobisawa, Yuki, Kaneko, Tomonori, Kaya, Takatoshi, Hatakeyama, Shingo, Mori, Kazuyuki, Sutoh Yoneyama, Mihoko, Okubo, Teppei, Mitsuzuka, Koji, Duivenvoorden, Wilhelmina, Pinthus, Jehonathan H., Hashimoto, Yasuhiro, Ito, Akihiro, Koie, Takuya, Suda, Yoshihiko, Gardiner, Robert A., Ohyama, Chikara
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2019
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6676104/ https://www.ncbi.nlm.nih.gov/pubmed/31145522 http://dx.doi.org/10.1111/cas.14082

Ejemplares similares

Breast Milk Oligosaccharides Contain Immunomodulatory Glucuronic Acid and LacdiNAc
por: Jin, Chunsheng, et al.
Publicado: (2023)

An Automated Micro-Total Immunoassay System for Measuring Cancer-Associated α2,3-linked Sialyl N-Glycan-Carrying Prostate-Specific Antigen May Improve the Accuracy of Prostate Cancer Diagnosis
por: Ishikawa, Tomokazu, et al.
Publicado: (2017)

Expression of LacdiNAc Groups on N-Glycans among Human Tumors Is Complex
por: Hirano, Kiyoko, et al.
Publicado: (2014)

Characteristics of α2,3‐sialyl N‐glycosylated PSA as a biomarker for clinically significant prostate cancer in men with elevated PSA level
por: Yoneyama, Tohru, et al.
Publicado: (2021)

Biosynthesis and Biological Significances of LacdiNAc Group on N- and O-Glycans in Human Cancer Cells
por: Hirano, Kiyoko, et al.
Publicado: (2022)

Precision N‐glycoproteomics reveals elevated LacdiNAc as a novel signature of intrahepatic cholangiocarcinoma
por: Li, Jun, et al.
Publicado: (2021)

Structural and binding characterization of the LacdiNAc-specific adhesin (LabA; HopD) exodomain from Helicobacter pylori
por: Paraskevopoulou, Vasiliki, et al.
Publicado: (2020)

Wisteria floribunda Agglutinin and Its Reactive-Glycan-Carrying Prostate-Specific Antigen as a Novel Diagnostic and Prognostic Marker of Prostate Cancer
por: Hagiwara, Kazuhisa, et al.
Publicado: (2017)

Testicular Metastasis of Prostate Cancer: A Case Report
por: Kusaka, Ayumu, et al.
Publicado: (2014)

Endoplasmic reticulum protein ERp46 in prostate adenocarcinoma
por: Duivenvoorden, Wilhelmina C.M., et al.
Publicado: (2017)

Recent progress and perspectives on prostate cancer biomarkers
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Core2 O-glycan-expressing prostate cancer cells are resistant to NK cell immunity
por: OKAMOTO, TEPPEI, et al.
Publicado: (2013)

Safety of heparin bridging therapy for transrectal ultrasound-guided prostate biopsy in patients requiring temporary discontinuation of antithrombotic agents
por: Hamano, Itsuto, et al.
Publicado: (2016)

Narrative review of urinary glycan biomarkers in prostate cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2021)

Utility of total cell-free DNA levels for surgical damage evaluation in patients with urological surgeries
por: Konishi, Sakae, et al.
Publicado: (2021)

I‐branching N‐acetylglucosaminyltransferase regulates prostate cancer invasiveness by enhancing α5β1 integrin signaling
por: Mikami, Jotaro, et al.
Publicado: (2016)

Serum N-glycan profiling is a potential biomarker for castration-resistant prostate cancer
por: Matsumoto, Teppei, et al.
Publicado: (2019)

Both radical prostatectomy following treatment with neoadjuvant LHRH agonist and estramustine and radiotherapy following treatment with neoadjuvant hormonal therapy achieved favorable oncological outcome in high-risk prostate cancer: a propensity-score matching analysis
por: Koie, Takuya, et al.
Publicado: (2014)

Thromboembolism in Patients with Bladder Cancer: Incidence, Risk Factors and Prevention
por: Zareba, Piotr, et al.
Publicado: (2018)

Solitary Fibrous Tumor of the Prostate Which Was Initially Misdiagnosed as Prostate Cancer
por: Osamu, Soma, et al.
Publicado: (2017)

Clinical implication of a quantitative frailty assessment tool for prognosis in patients with urological cancers
por: Soma, Osamu, et al.
Publicado: (2018)

Neoadjuvant gemcitabine and carboplatin followed by immediate cystectomy may be associated with a survival benefit in patients with clinical T2 bladder cancer
por: Koie, Takuya, et al.
Publicado: (2014)

Renal metastasis of ovarian granulosa cell tumor
por: Togashi, Kyo, et al.
Publicado: (2022)

Presence of transient hydronephrosis immediately after surgery has a limited influence on renal function 1 year after ileal neobladder construction
por: Narita, Takuma, et al.
Publicado: (2017)

Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study
por: Iwamura, Hiromichi, et al.
Publicado: (2015)

Detection of Core2 β-1,6-N-Acetylglucosaminyltransferase in Post-Digital Rectal Examination Urine Is a Reliable Indicator for Extracapsular Extension of Prostate Cancer
por: Kojima, Yuta, et al.
Publicado: (2015)

The ‘C’ Words: parallels and analogies between Prostate Cancer and Covid-19
por: Klotz, Laurence, et al.
Publicado: (2021)

Slow Gait Speed and Rapid Renal Function Decline Are Risk Factors for Postoperative Delirium after Urological Surgery
por: Sato, Tendo, et al.
Publicado: (2016)

Feasibly of axitinib as first-line therapy for advanced or metastatic renal cell carcinoma: a single-institution experience in Japan
por: Koie, Takuya, et al.
Publicado: (2015)

Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Correction: Renal Function Outcomes and Risk Factors for Risk Factors for Stage 3B Chronic Kidney Disease after Urinary Diversion in Patients with Muscle Invasive Bladder Cancer
por: Hatakeyama, Shingo, et al.
Publicado: (2016)

Utility of plasma cell‐free DNA in metastatic castration‐resistant prostate cancer
por: Hamano, Itsuto, et al.
Publicado: (2020)

Significance of pelvic lymph node dissection during radical prostatectomy in high-risk prostate cancer patients receiving neoadjuvant chemohormonal therapy
por: Iwamura, Hiromichi, et al.
Publicado: (2022)

Robot‐assisted radical cystectomy in a patient with muscle‐invasive bladder cancer following radiotherapy for prostate cancer
por: Kubota, Yuka, et al.
Publicado: (2019)

The Impact of Glycosylation of Osteopontin on Urinary Stone Formation
por: Anan, Go, et al.
Publicado: (2019)

Efficacy and Safety of Silodosin and Dutasteride Combination Therapy in Acute Urinary Retention due to Benign Prostatic Hyperplasia: A Single-Arm Prospective Study
por: Hagiwara, Kazuhisa, et al.
Publicado: (2016)

Endoplasmic Reticulum Protein ERp46 in Renal Cell Carcinoma
por: Duivenvoorden, Wilhelmina C. M., et al.
Publicado: (2014)

Tubulocystic renal cell carcinoma in the left kidney: a case report
por: Ishibashi, Yusuke, et al.
Publicado: (2014)

Humoral response after SARS-CoV-2 mRNA vaccination in patients with prostate cancer using steroids
por: Ishii, Noritaka, et al.
Publicado: (2022)

Galectin Binding to Neo-Glycoproteins: LacDiNAc Conjugated BSA as Ligand for Human Galectin-3
por: Böcker, Sophia, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_jhrdgh0cm626j51il4u5b4jlbe